NAGE
Niagen Bioscience, Inc. SEC filings
Every EDGAR filing for Niagen Bioscience, Inc. (NAGE), newest first, with AI summaries and stories.
- Ticker
- NAGE
- CIK
- 1386570
- Latest filing
- Aug 4
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
10-QNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.NAGELIVE SCHEDULE 13GNiagen Bioscience, Inc.NAGELIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
424B5Niagen Bioscience, Inc.NAGELIVE EFFECTNiagen Bioscience, Inc.NAGELIVE 4Niagen Bioscience, Inc.NAGELIVE 3 insider filings
Carlos Luis Lopez, insider filing for NAGE
Show all 3
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
Carlos Luis Lopez, reporting
8-KNiagen Bioscience, Inc.NAGELIVE S-3Niagen Bioscience, Inc.NAGELIVE 4Niagen Bioscience, Inc.NAGELIVE 7 insider filings
Wing Tak Wendy YU, insider filing for NAGE
Show all 7
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
Wing Tak Wendy Yu, reporting
10-QNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.NAGELIVE ARSNiagen Bioscience, Inc.NAGELIVE DEFA14ANiagen Bioscience, Inc.NAGELIVE DEF 14ANiagen Bioscience, Inc.NAGELIVE 4Niagen Bioscience, Inc.NAGELIVE Robert N Fried, insider filing for NAGE
Robert N Fried, reporting
8-KNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.NAGELIVE 10-KNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.NAGELIVE 4Niagen Bioscience, Inc.NAGELIVE 3 insider filings
Carlos Luis Lopez, insider filing for NAGE
Show all 3
- 4Insider filing for NAGE
- 4Insider filing for NAGE
- 4Insider filing for NAGE
Carlos Luis Lopez, reporting
SCHEDULE 13G/ANiagen Bioscience, Inc.NAGELIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
8-KNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.NAGELIVE 8-KNiagen Bioscience, Inc.LIVE 10-QNiagen Bioscience, Inc.LIVE SCHEDULE 13GNiagen Bioscience, Inc.LIVE Ownership stake disclosure by VANGUARD GROUP INC
VANGUARD GROUP INC, filed by